MarketPeel
Insider Trading Intelligence
GD

Gregory D. Davis

SGMO
HEAD OF RESEARCH & TECHNOLOGY · SANGAMO THERAPEUTICS, INC · CIK 0002041855
FILING MIX · LIFETIME17%/83%
BUYS
3
SELLS
15
TOTAL VALUE
$76.0K
COMPANIES
1
ACTIVE SINCE
Nov 2024
HOLDINGS NOW
115,284
AVG SELL PX
$0.55
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Gregory D. Davis, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-50.00%+0.05%-50.05%-50.05%
14d1+100.00%-50.00%+3.18%-53.18%-53.18%
30d1+100.00%-40.00%
60d1+100.00%-34.62%+5.00%-39.61%-39.61%
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SGMO · 115,284 shares · as of Apr 22, 2026
056,250112,500168,750225,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 3 buys / 15 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
69,827$0.25$17.7K115,284Apr 22, 2026Apr 23, 2026View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
225,000225,000Apr 1, 2026Apr 3, 2026View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
5,119$0.47$2.4K185,111Feb 25, 2026Feb 26, 2026View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
832$0.47$393190,230Feb 24, 2026Feb 26, 2026View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
7,721$0.40$3.1K191,062Jan 22, 2026Jan 26, 2026View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
723$0.42$301193,791Nov 24, 2025Nov 26, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
6,708$0.66$4.4K194,514Oct 22, 2025Oct 24, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
723$0.59$424201,222Aug 24, 2025Aug 26, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
6,708$0.48$3.2K201,945Jul 22, 2025Jul 24, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
723$0.47$342208,653May 24, 2025May 28, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
6,708$0.78$5.2K209,376Apr 22, 2025Apr 24, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
507$0.96$485166,358Feb 25, 2025Feb 26, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
49,726216,084Feb 25, 2025Feb 26, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
99,45499,454Feb 25, 2025Feb 26, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
705$1.00$705166,865Feb 24, 2025Feb 26, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
30,456$1.15$35.0K167,570Jan 22, 2025Jan 24, 2025View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
505$1.94$980201,863Nov 25, 2024Nov 26, 2024View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
Head of Research & Technology
721$1.88$1.4K202,368Nov 24, 2024Nov 26, 2024View →
Other insiders · SGMO
Loading peer insiders…
About this filer
CIK 0002041855
ROLE
Head of Research & Technology
PRIMARY
SGMO
COMPANIES
1
ACTIVE SINCE
Nov 2024
MARKETPEEL · /INSIDER/0002041855DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback